What Is the Overall Sentiment on CVS Health (CVS) Shares?

CVS Health stock is trading -24.45% below its average target price of $90.16 after dropping -1.2% during today's morning session. Analysts are giving the large-cap Pharmaceutical Retail company an average rating of buy and target prices ranging from $76.0 to $110.0 per share.

CVS Health's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.1%. The stock's short ratio is 1.96. The company's insiders own 0.18% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 79.9%. In conclusion, we believe there is mixed market sentiment regarding CVS Health.

Institutions Invested in CVS Health

Date Reported Holder Percentage Shares Value
2023-06-30 Vanguard Group Inc 9% 116,676,882 $7,948,029,522
2023-06-30 Blackrock Inc. 7% 93,734,850 $6,385,218,239
2023-06-30 State Street Corporation 4% 55,877,387 $3,806,367,755
2023-06-30 Morgan Stanley 3% 33,253,424 $2,265,223,334
2023-06-30 Capital World Investors 2% 30,490,802 $2,077,033,515
2023-06-30 Geode Capital Management, LLC 2% 23,325,287 $1,588,918,614
2023-06-30 FMR, LLC 2% 21,292,797 $1,450,465,390
2023-06-30 Invesco Ltd. 1% 17,002,487 $1,158,209,461
2023-06-30 Bank of America Corporation 1% 16,551,119 $1,127,462,271
2023-06-30 Dodge & Cox Inc 1% 16,024,422 $1,091,583,670
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.